InvestorsHub Logo
Followers 243
Posts 18105
Boards Moderated 0
Alias Born 02/11/2009

Re: None

Thursday, 08/02/2018 11:57:35 PM

Thursday, August 02, 2018 11:57:35 PM

Post# of 879
BIVI has 8 drugs? "The Company plans on developing the following eight (8) pharmaceutical compounds:

Multi Drug Resistant Bacteria (”Superbugs”)
Nano Efflux Pump Blocker
(“NEB”)

Nano Antibiotic
(“NA”)
Methicillin-resistant Staphylococcus aureus (MRSA) NEB-MRSA NA-MRSA
Drug-resistant tuberculosis ( MDR-TB and XDR-TB ) NEB-TB NA-TB
Drug-resistant Enterococcus NEB-EC NA-EC
Drug-resistant Streptococcus pneumonia NEB-SC NA-SC

Our drug discovery platform currently provides a multi-pronged level understanding of interactions between drug candidates and their bacterial targets and enables us to engineer antibiotics with enhanced characteristics to attack a Drug Resistant Bacteria with a multi-targeted approach. The Company plans on developing eight pharmaceutical compounds."

Very interesting! Anybody knows how they're going along with currently?
Thanks.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BIVI News